---
figid: PMC7464784__cancers-12-02252-g001
figlink: pmc/articles/PMC7464784/figure/cancers-12-02252-f001/
number: F1
caption: An illustration of glucose metabolism leading from the glycolytic pathway
  to the tricarboxylic acid cycle (TCA) and electron transport chain (ETC). (A) Targets
  and inhibitors of the glycolytic pathway, TCA, and ETC. These inhibitors target
  key enzymes/components, thereby regulating glucose metabolism. The bold red lines
  with rounded ends indicate the inhibitory effect of the various agents on target
  enzymes/components. Classical anticancer drugs like cisplatin, As2O3, and doxorubicin
  can modulate glycolytic enzymes. Some natural compounds (shown in the green color
  font) such as resveratrol, genistein, and shikonin can modify the activity of these
  enzymes. The blue arrows represent how metabolites of the glycolytic pathway contribute
  to other key biosynthetic pathways that support cancer cell survival and growth.
  The precursors for de novo biosynthesis of nucleotides are derived from ribose 5-phosphate
  of the pentose phosphate pathway (PPP), which is a side branch of glucose metabolic
  pathway. Likewise, 3-PG, a glycolytic intermediate, serves as a precursor for amino
  acid synthesis, thus fueling anabolic reactions necessary for cancer growth. Similarly,
  an enhanced lipogenesis controlled by an oncogenic signaling is often associated
  with an increased tumor glycolysis. Here, DHAP acts as an intermediate for lipid
  biosynthesis. (B) The various enzymes/components that contribute to drug resistance
  in cancers and how the non-glycolytic functions of these enzymes contribute to cancer
  progression is highlighted. The transcription factor, hypoxia-inducible factor-1
  (HIF-1), upregulates the expression of the key transporters and glycolytic enzymes,
  thereby promoting adaptive cancer cell metabolism and supporting tumor progression.
  Abbreviations; Glc = glucose, Glc-6-P = glucose-6-phosphate, F-6-P = fructose-6-phosphate,
  F-1,6-P = fructose 1,6 bisphosphate, G-3-P = glyceraldehyde 3 phosphate, DHAP =
  dihydroxyacetone phosphate, 1,3-BPG = 1,3-bisphosphoglycerate, 3-PG = 3-phosphoglycerate,
  2-PG = 2-phosphoglycerate, PEP = phosphoenolpyruvate, GLUT = glucose transporter,
  MCT1 = monocarboxylate transporter 1, SMI-4a = (5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione,
  3PO = 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one, 3BrPy = 3-bromopyruvate, 2DG
  = 2-deoxy-D-glucose, DCA = dichloroacetate.
pmcid: PMC7464784
papertitle: Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy
  in Breast Cancer.
reftext: Elizabeth Varghese, et al. Cancers (Basel). 2020 Aug;12(8):2252.
pmc_ranked_result_index: '1103'
pathway_score: 0.9478733
filename: cancers-12-02252-g001.jpg
figtitle: An illustration of glucose metabolism leading from the glycolytic pathway
  to the tricarboxylic acid cycle (TCA) and electron transport chain (ETC)
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7464784__cancers-12-02252-g001.html
  '@type': Dataset
  description: An illustration of glucose metabolism leading from the glycolytic pathway
    to the tricarboxylic acid cycle (TCA) and electron transport chain (ETC). (A)
    Targets and inhibitors of the glycolytic pathway, TCA, and ETC. These inhibitors
    target key enzymes/components, thereby regulating glucose metabolism. The bold
    red lines with rounded ends indicate the inhibitory effect of the various agents
    on target enzymes/components. Classical anticancer drugs like cisplatin, As2O3,
    and doxorubicin can modulate glycolytic enzymes. Some natural compounds (shown
    in the green color font) such as resveratrol, genistein, and shikonin can modify
    the activity of these enzymes. The blue arrows represent how metabolites of the
    glycolytic pathway contribute to other key biosynthetic pathways that support
    cancer cell survival and growth. The precursors for de novo biosynthesis of nucleotides
    are derived from ribose 5-phosphate of the pentose phosphate pathway (PPP), which
    is a side branch of glucose metabolic pathway. Likewise, 3-PG, a glycolytic intermediate,
    serves as a precursor for amino acid synthesis, thus fueling anabolic reactions
    necessary for cancer growth. Similarly, an enhanced lipogenesis controlled by
    an oncogenic signaling is often associated with an increased tumor glycolysis.
    Here, DHAP acts as an intermediate for lipid biosynthesis. (B) The various enzymes/components
    that contribute to drug resistance in cancers and how the non-glycolytic functions
    of these enzymes contribute to cancer progression is highlighted. The transcription
    factor, hypoxia-inducible factor-1 (HIF-1), upregulates the expression of the
    key transporters and glycolytic enzymes, thereby promoting adaptive cancer cell
    metabolism and supporting tumor progression. Abbreviations; Glc = glucose, Glc-6-P
    = glucose-6-phosphate, F-6-P = fructose-6-phosphate, F-1,6-P = fructose 1,6 bisphosphate,
    G-3-P = glyceraldehyde 3 phosphate, DHAP = dihydroxyacetone phosphate, 1,3-BPG
    = 1,3-bisphosphoglycerate, 3-PG = 3-phosphoglycerate, 2-PG = 2-phosphoglycerate,
    PEP = phosphoenolpyruvate, GLUT = glucose transporter, MCT1 = monocarboxylate
    transporter 1, SMI-4a = (5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione,
    3PO = 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one, 3BrPy = 3-bromopyruvate,
    2DG = 2-deoxy-D-glucose, DCA = dichloroacetate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC2A1
  - SDHD
  - PFKFB3
  - HAS1
  - VIT
  - ABCD1
  - GAPDH
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - LDHA
  - PRKG1
  - PAEP
  - ATR
  - SETD2
  - HIF1A
  - ARNT
  - MT-CO1
  - Lactate
  - Quercetin
  - lonidamine
  - Tamoxifen
  - Apigenin
  - Resveratrol
  - Silybin
  - ATP
  - Cisplatin
  - Euxanthone
  - Xanthohumol
  - Metformin
  - Ribose-5-phosphate
  - PFK15
  - F-2,6-BP
  - Nucleotide
  - Vit Ka
  - Vit
  - Shikonin
  - Phosphoglucose
  - Fructose-2
  - Glyceraidehyde phosphate
  - Phosphoglycerate
  - Pyruvate
  - Pyruvate dehydrogenane
  - DHAP
  - 1,3-8PG
  - 1,3-BPG
  - Amino acid
  - nucleotide
  - Serine
  - Methotrexate
  - Tamoxilen
  - Oxaliplatin
  - Lapatinib
  - Chidamide
  - DCA
  - Taxol
  - TCA
  - Acetyl
  - cancer
  - tumor
  - apoplosis
  - hypovia tolerance
  - ALD
genes:
- word: GLUT
  symbol: GLUT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: GLUT
  symbol: GLUT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: PGI
  symbol: PGL
  source: hgnc_prev_symbol
  hgnc_symbol: SDHD
  entrez: '6392'
- word: PFKFB3
  symbol: PFKFB3
  source: hgnc_symbol
  hgnc_symbol: PFKFB3
  entrez: '5209'
- word: has
  symbol: HAS
  source: hgnc_prev_symbol
  hgnc_symbol: HAS1
  entrez: '3036'
- word: Vit
  symbol: VIT
  source: hgnc_symbol
  hgnc_symbol: VIT
  entrez: '5212'
- word: PGI
  symbol: PGL
  source: hgnc_prev_symbol
  hgnc_symbol: SDHD
  entrez: '6392'
- word: ALD-
  symbol: ALD
  source: hgnc_prev_symbol
  hgnc_symbol: ABCD1
  entrez: '215'
- word: GAPDH
  symbol: GAPDH
  source: hgnc_symbol
  hgnc_symbol: GAPDH
  entrez: '2597'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLAT
  entrez: '1737'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA1
  entrez: '5160'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA2
  entrez: '5161'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHB
  entrez: '5162'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHX
  entrez: '8050'
- word: LDHA
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: ALD
  symbol: ALD
  source: hgnc_prev_symbol
  hgnc_symbol: ABCD1
  entrez: '215'
- word: ALD
  symbol: ALD
  source: hgnc_prev_symbol
  hgnc_symbol: ABCD1
  entrez: '215'
- word: GAPDH
  symbol: GAPDH
  source: hgnc_symbol
  hgnc_symbol: GAPDH
  entrez: '2597'
- word: GAPDH
  symbol: GAPDH
  source: hgnc_symbol
  hgnc_symbol: GAPDH
  entrez: '2597'
- word: PGK
  symbol: PGK
  source: hgnc_alias_symbol
  hgnc_symbol: PRKG1
  entrez: '5592'
- word: РЕP
  symbol: PEP
  source: hgnc_alias_symbol
  hgnc_symbol: PAEP
  entrez: '5047'
- word: PEP
  symbol: PEP
  source: hgnc_alias_symbol
  hgnc_symbol: PAEP
  entrez: '5047'
- word: ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: =HIF-1
  symbol: HIF1
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: =HIF-1
  symbol: HIF1
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: LDHA
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLAT
  entrez: '1737'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA1
  entrez: '5160'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA2
  entrez: '5161'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHB
  entrez: '5162'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHX
  entrez: '8050'
- word: Col
  symbol: COI
  source: hgnc_alias_symbol
  hgnc_symbol: MT-CO1
  entrez: '4512'
chemicals:
- word: Lactate
  source: MESH
  identifier: D019344
- word: Quercetin
  source: MESH
  identifier: D011794
- word: lonidamine
  source: MESH
  identifier: C016371
- word: Tamoxifen
  source: MESH
  identifier: D013629
- word: Apigenin
  source: MESH
  identifier: D047310
- word: Resveratrol
  source: MESH
  identifier: C059514
- word: Silybin
  source: MESH
  identifier: C440975
- word: ATP
  source: MESH
  identifier: D000255
- word: Cisplatin
  source: MESH
  identifier: D002945
- word: Euxanthone
  source: MESH
  identifier: C404221
- word: Xanthohumol
  source: MESH
  identifier: C104536
- word: Metformin
  source: MESH
  identifier: D008687
- word: Ribose-5-phosphate
  source: MESH
  identifier: C031626
- word: PFK15
  source: MESH
  identifier: C043951
- word: F-2,6-BP
  source: MESH
  identifier: C071196
- word: Nucleotide
  source: MESH
  identifier: D009711
- word: Vit Ka
  source: MESH
  identifier: D024505
- word: Vit
  source: MESH
  identifier: D024505
- word: Shikonin
  source: MESH
  identifier: C016101
- word: Phosphoglucose
  source: MESH
  identifier: C028071
- word: Fructose-2
  source: MESH
  identifier: D005632
- word: Glyceraidehyde phosphate
  source: MESH
  identifier: D010710
- word: Phosphoglycerate
  source: MESH
  identifier: C008885
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Pyruvate dehydrogenane
  source: MESH
  identifier: D011773
- word: DHAP
  source: MESH
  identifier: C017202
- word: 1,3-8PG
  source: MESH
  identifier: C100573
- word: 1,3-BPG
  source: MESH
  identifier: C091495
- word: Amino acid
  source: MESH
  identifier: D000596
- word: nucleotide
  source: MESH
  identifier: D009711
- word: Serine
  source: MESH
  identifier: C047902
- word: Methotrexate
  source: MESH
  identifier: D008727
- word: Tamoxilen
  source: ''
  identifier: ''
- word: Oxaliplatin
  source: MESH
  identifier: C030110
- word: Lapatinib
  source: MESH
  identifier: C490728
- word: Chidamide
  source: MESH
  identifier: C547816
- word: DCA
  source: MESH
  identifier: C048628
- word: Taxol
  source: MESH
  identifier: D017239
- word: TCA
  source: MESH
  identifier: C000589078
- word: Acetyl
  source: MESH
  identifier: C011632
diseases:
- word: cancer
  source: MESH
  identifier: D009369
- word: tumor
  source: MESH
  identifier: D009369
- word: apoplosis
  source: ''
  identifier: ''
- word: hypovia tolerance
  source: MESH
  identifier: D018149
- word: ALD
  source: MESH
  identifier: D000326
figid_alias: PMC7464784__F1
redirect_from: /figures/PMC7464784__F1
figtype: Figure
---
